LK
Lakefront Biotherapeutics
LKFT.AS · AMS
23.18 € -0.52% (-0.12 €)
1M -2.43%
Market Cap 1.52B €
P/E Ratio 3.12x
Div. Yield -
ROE 16.88%
Piotroski F-Score Moderate
4/9Valuation
99 /100
Cheap P/E 3.12x
EV/EBITDA 4.45x
P/S 1.46x
Growth
-
N/A EPS growth N/A
Rev. growth N/A
FCF growth N/A
Profitability
70 /100
Strong Gross margin 98.01%
Net margin 46.83%
Op. margin 36.43%
Quality
69 /100
Excellent ROIC 12.03%
ROE 16.88%
ROA 14.49%
Debt
100 /100
Low Debt/Equity 0.00x
Current ratio 30.48x
Int. coverage 144.35x
Stability
0 /100
Unstable Beta 0.12x
Rev. volatility N/A
EPS volatility N/A
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o LKFT.AS
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Henry Gosebruch
Employees
452
Headquarters
Mechelen
Prihajajoči dogodki
12 NOV.
Earnings
Upcoming earnings report